Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE 80MG TABLET Resolved 2018-05-01 2018-09-11 47680
APO-GLICLAZIDE 80MG TABLET Resolved 2020-09-02 2020-09-14 123561
APO-GLICLAZIDE 80MG TABLET Resolved 2022-12-16 2022-12-23 178760
APO-GLICLAZIDE 80MG TABLET Resolved 2023-04-21 2023-06-29 189988
APO-GLICLAZIDE 80MG TABLET Actual shortage 2025-04-04 2025-04-25 254165
APO-GLICLAZIDE 80MG TABLET Resolved 2020-02-13 2020-04-14 105997
APO-GLICLAZIDE 80MG TABLET Resolved 2022-01-28 2022-02-08 153780
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-27 2024-08-07 231493
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2024-08-29 2024-11-01 236261
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-04 2025-01-10 239373
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-19 2021-03-15 134433
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-05-31 217481
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-19 2024-06-21 225793
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-06 2025-04-04 249766

Showing 1341 to 1360 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-LEVOCARB 25MG 250MG TABLET Discontinued 2018-09-07 2019-02-07 60576
APO-LISINOPRIL 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-LISINOPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-LOPERAMIDE 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LOSARTAN 25MG TABLET Discontinued 2019-02-01 2019-02-02 74376
APO-LOSARTAN 50MG TABLET Discontinued 2018-09-10 2018-09-15 60987
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-07 2018-12-28 60600
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603

Showing 201 to 220 of 359